Drug & supplement interaction

Cannabichromene (cbc) + Ipilimumab

Ipilimumab brand name: Yervoy.

No Known Interaction
Medically reviewed by · Updated June 2026 · Pair last verified Sep 20, 2026
The bottom line No known interaction

We found no known interaction between Cannabichromene (cbc) and Ipilimumab in our sources. Absence of a documented interaction is not the same as proven safety, and does not guarantee one does not exist. Do not start, stop, or change a medication or supplement based on this page; confirm with your pharmacist or doctor first.

Know someone taking this? Share
Facebook Post Reddit Email
On this page
Interaction report

Cannabichromene (cbc) and Ipilimumab

We checked these two against our interaction database. Here is what we found.

No Known Interaction Found

We did not find a documented interaction between Ipilimumab and Cannabichromene (cbc) in our sources. This does not guarantee that the combination is completely free of risk — there is often limited research on supplements and herbal products, especially around drug interactions.

If you decide to take both, the practical routine is simple: add one new thing at a time and note the date you started it. If the combination is going to disagree with you, it usually shows in the first days to a couple of weeks — and a start date turns “I’ve been feeling off” into something a pharmacist can actually work with. Do not stop a prescribed medicine on your own.

Always talk with your pharmacist or doctor before making changes to your medications or supplements, particularly if you take several medications or have an ongoing health condition.

Cannabichromene (cbc) safety at a glance

Cannabichromene (c... overall Not established Human safety data are very limited, so its long-term safety is not established.
Pregnancy Avoid Not enough safety data; cannabinoids are best avoided during pregnancy.
Breastfeeding Avoid Cannabinoids can pass into breast milk, so avoid use while breastfeeding.

Safety guidance is general; always confirm with your pharmacist or doctor for your situation.

Still wondering about combining Ipilimumab and Cannabichromene (cbc)? Ask Dr. Brian Staiger, PharmD, BCPS directly ›
Keep it in perspective

Cannabichromene (cbc) Does Interact With Other Medications

Cannabichromene (cbc) has 248 moderate known drug interactions in our database — Ipilimumab isn’t one of them. If you take anything else, check it against the full list below.

Moderate 248 No known interaction 2,582 (incl. Ipilimumab)
Taking anything else?

Check Another of Your Medications Against Cannabichromene (cbc)

Covers the 2,830 medications we’ve checked against Cannabichromene (cbc). Pick one to open its full report.

What to actually watch for

What Ipilimumab’s Own FDA Label Lists

This is not an interaction — none of it involves Cannabichromene (cbc). These are the most notable effects listed in the ADVERSE REACTIONS section of Ipilimumab’s own FDA label, for the medication by itself. Knowing the drug’s own list makes it easier to work out the likely cause if something new turns up while you take both. 10 of them are worth acting on rather than waiting out — marked below.

  • Low magnesium Worth acting on
  • A change in thyroid levels Worth acting on
  • A bowel blockage Worth acting on
  • Severe muscle breakdown Worth acting on
  • Dehydration Worth acting on
  • Trouble swallowing Worth acting on
  • High potassium Worth acting on
  • Low sodium Worth acting on
  • Low blood sugar Worth acting on
  • Low potassium Worth acting on

Showing the 10 most notable of 61 label-listed effects — ranked by how unusual each one is across medicines generally, with serious effects weighted up.

From the ADVERSE REACTIONS section of the FDA label for Ipilimumab. Read the label on DailyMed › Where a percentage is shown, it is the share of 42,912 voluntary FDA FAERS reports for Ipilimumab that mention that effect — a reporting proportion, not an incidence rate and not evidence the drug caused it. Cannabichromene (cbc)’s licensed record lists no adverse effects our clinical vocabulary could match, so there is no Cannabichromene (cbc) side to compare — that is a limit of the record, not a statement that Cannabichromene (cbc) has no side effects.

How much people look this up

Where Cannabichromene (cbc) and Ipilimumab Sit Against Everything Else

Out of every supplement and medication people look up on HelloPharmacist, here is where these two land this week — and which way each has been moving.

Supplement Cannabichromene (cbc)
Steady interest

#1,148 of 1,452 supplements looked up here in the last 7 days

29 days ago today
Medication Ipilimumab
Top 25%

#357 of 2,830 medications looked up here in the last 7 days

29 days ago today

Position among everything looked up on this site, not a measure of how commonly either one is used or how important it is. A supplement can climb this list because of a news story. It counts every request to the page, automated ones included, and nothing here identifies anyone.

Where does our data come from?
  • Source: the Natural Medicines (TRC Healthcare) clinical database — the evidence-graded professional reference for herb & supplement interactions.
  • Citation library: 103,510 references behind our interaction content, 65,311 of them resolved to verified PubMed/DOI sources. See every Cannabichromene (cbc) reference on this page ↓
  • Freshness: we automatically re-check this combination every week — this pair was last verified September 20, 2026. The Cannabichromene (cbc) and Ipilimumab records this page draws on were last updated June 20, 2026.
  • What “no known interaction” means: no documented interaction in the sources above — not a guarantee of safety. Supplements are studied far less than prescription drugs, so we say exactly what the evidence supports, and nothing more.
Data structure & sourcing designed and verified by .
Supplement

About Cannabichromene (cbc)

What is Cannabichromene (cbc)?

Cannabichromene (cbc)
  • Pain relief
  • Inflammation
  • Mood and anxiety
  • Skin and acne concerns
  • Brain and nerve health

Cannabichromene (CBC) is a non-intoxicating cannabinoid found in the cannabis plant that is being studied for possible pain, anti-inflammatory, and nervous-system effects. Almost all current evidence comes from laboratory and animal research, so we do not yet know how well it works or how safe it is in people. Talk with your pharmacist or doctor before using any CBC product, and avoid it during pregnancy and breastfeeding.

Cannabaceae · Flowers and resin of the cannabis plant (where the cannabinoid is concentrated) · Oils and tinctures, capsules, edibles, full-spectrum hemp extracts, vape products

An interaction check asks whether these two react with each other — it does not ask whether Cannabichromene (cbc) is a good idea for someone in your situation. Here is what our Cannabichromene (cbc) record says about it on its own.

Cannabichromene (cbc): dosing

There is no established or standardized dose for CBC. Because human research is so limited, experts cannot recommend a specific amount that is known to be safe or effective.If you choose to try a CBC product, follow the directions on the product label and consider starting low. Look for products that have been tested by an independent lab and provide a certificate of analysis.

From our Cannabichromene (cbc) monograph — the full record covers uses, side effects and every documented interaction.

Read the full Cannabichromene (cbc) monograph & all interactions
Medication

About Ipilimumab Injection

What Is Ipilimumab Injection Used For?

Brand name: Yervoy

Yervoy (ipilimumab) is used to treat a range of advanced cancers. As a single agent, Yervoy treats unresectable (cannot be surgically removed) or metastatic melanoma in adults and children 12 and older, and is also used as adjuvant (after-surgery) treatment in adults with melanoma that has spread to nearby lymph nodes. Most of its other uses are in combination with nivolumab.

In combination with nivolumab, Yervoy is indicated for advanced renal cell carcinoma (kidney cancer), MSI-H or dMMR metastatic colorectal cancer (in adults and children 12+), unresectable or metastatic hepatocellular carcinoma (liver cancer), metastatic non-small cell lung cancer, unresectable malignant pleural mesothelioma, and unresectable advanced or metastatic esophageal squamous cell carcinoma. Some of these uses require tumor testing for specific markers (such as PD-L1 expression or MSI-H/dMMR status) before treatment begins.

Most-Reported Side Effects for Ipilimumab

From FAERS, the FDA’s public side-effect reporting system (42,912 reports, all brands). Reports are voluntary and are not proof the drug caused the effect.

Malignant neoplasm progression 3,782 reports
Diarrhea 3,128 reports
Colitis 2,316 reports
Fever 2,057 reports
Rash 1,805 reports
See full Ipilimumab Injection drug information
Keep checking

Other Drugs & Cannabichromene (cbc)

Browse every other medication we’ve checked against Cannabichromene (cbc) — both the ones with a known interaction and the ones without. Select any drug for the full detail.

0Major
248Moderate
0Minor
2,581No known interaction
248 Moderate 2,581 No interaction
Moderate

248 interactions

Showing 60 of 248 moderate interactions — see all 248 on the Cannabichromene (cbc) page.

No interaction 2,581 drugs checked — show the list

We also checked Cannabichromene (cbc) against these medications and found no known interaction in our sources. Open any page to confirm.

Showing the 60 most looked-up of 2,581 medications checked with no known interaction — see the full Cannabichromene (cbc) list.

See the full Cannabichromene (cbc) interactions page
See every supplement checked against Ipilimumab, ranked by severity
Evidence & sources

Cannabichromene (cbc) References

The 1 references that drive our Cannabichromene (cbc) monograph and interaction data, from the evidence-graded Natural Medicines (TRC Healthcare) database. Citations with a link open the study on PubMed or the publisher’s site.

  1. Hatoum NS, Davis WM, Waters IW, Elsohly MA, Turner CE. Synergism of cannabichromene and CNS depressants in mice. Gen Pharmacol. 1981;12(5):351-6. PubMed

Medication overviews come from MedlinePlus (NIH); supplement label data from the NIH Dietary Supplement Label Database. Content is written and reviewed by licensed HelloPharmacist pharmacists — see our data sources and editorial standards.

Pharmacist Counseling Corner

Taking Cannabichromene (cbc) and Ipilimumab Together: Common Questions

Is it safe to take Cannabichromene (cbc) with Ipilimumab?
We do not list a known interaction between Cannabichromene (cbc) and Ipilimumab. That does not guarantee the combination is risk-free, so confirm with your pharmacist or doctor — especially if you take other medications or have a health condition.
Does Cannabichromene (cbc) interact with any other medications?
Yes. Cannabichromene (cbc) has 248 documented drug interactions in our database — Ipilimumab is simply not one of them. If you take anything else, it is worth checking each one; they are all listed on this page.

Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy

Where next

Keep Exploring

Cannabichromene (cbc) monograph Uses, safety profile, and every drug interaction in one place Ipilimumab Injection drug information The full plain-English guide to this medication Ipilimumab supplement interactions Every supplement checked against Ipilimumab, ranked by severity Supplement interaction checker Check any supplement or product against your medications Browse medications A–Z Every drug we’ve checked against herbs & supplements References The 1 citations behind this page Ask a pharmacist Free, personal answer from our licensed team

Still Have a Question About Ipilimumab and Cannabichromene (cbc)?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.